Amedalin (UK-3540-1) is an antidepressant which was synthesized in the early 1970s but was never marketed. It is a selective norepinephrine reuptake inhibitor with no significant effects on the reuptake of serotonin and dopamine and no antihistamine or anticholinergic properties.
This page contains content from the copyrighted Wikipedia article "Amedalin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
